News Videos

DCGI Grants Corbevax for kids aged 12-18 years

The Drugs Controller General of has approved the Biological E Limited’s COVID-19 vaccine Corbevax as emergency use authorisation (EUA) for the 12-18 years age group. As we know the DCGI has already approved the Corbevax as EUA situations in adults in December 2021. The Corbevax vaccine is intramuscularly injected with two doses of 0.5ml each time with 28 days apart and can be stored at 2 to 8 degrees Celsius temperature.